Table 27. Oregon Senate Bill 737 priority persistent pollutants detected in wastewater-treatment-plant (WWTP) effluent, Columbia River Basin, Washington and Oregon, 2008–09.
[CAS No.: Chemical Abstract Service Registry Number® is a Registered Trademark of the American Chemical Society. CAS recommends the verification of the CASRNs through CAS Client ServicesSM. Plan initiation level (PIL; SB 737): From Oregon Department of Environmental Quality (2010a). Abbreviatons: µg/L, micrograms per liter; E, estimated]
CAS No. |
Chemical name |
Plan
initiation level (µg/L) |
Number of WWTPs with detections |
Number of WWTPs with detections
greater than PIL |
Range of
detections
(µg/L) |
WWTPs
with detections |
Detected in WWTP effluent at concentrations greater than the PIL |
57-88-5 |
Cholesterol |
0.06 |
9 |
9 |
Present–E 6.3 |
see table 9 |
360-68-9 |
Coprostanol |
0.04 |
9 |
9 |
Present–E 5.8 |
see table 9 |
120-12-7 |
Anthracene |
0.01 |
1 |
1 |
Present |
St. Helens, see table 9 |
206-44-0 |
Fluoranthene |
0.04 |
1 |
1 |
E 0.11 |
Wenatchee, see table 9 |
Detected in WWTP effluent at concentrations less than the PIL |
5103-71-9 |
cis-Chlordane |
2 |
9 |
0 |
0.00002–0.00019 |
see table 13 |
5103-74-2 |
trans-Chlordane |
2 |
9 |
0 |
0.00001–0.00019 |
see table 13 |
2921-88-2 |
Chlorpyrifos |
0.04 |
4 |
0 |
0.0000–0.00043 |
see table 13 |
60-57-1 |
Dieldrin |
0.002 |
5 |
0 |
0.00001–0.00017 |
see table 13 |
120068-37-3 |
Fipronil |
15 |
7 |
0 |
Present–E 0.13 |
see tables 13 and 14 |
1222-05-5 |
Galaxolide (HHCB) |
29 |
9 |
0 |
0.38–2.5 |
see table 9 |
118-74-1 |
Hexachlorobenzene (HCB) |
1 |
1 |
0 |
Present |
Umatilla, see table 13 |
22967-92-6 |
Methylmercury |
0.004 |
7 |
0 |
0.00006–0.0004 |
see table 15 |
5103-73-1 |
cis-Nonachlor |
2 |
2 |
0 |
Present –0.00001 |
see table 13 |
39765-80-5 |
trans-Nonachlor |
2 |
8 |
0 |
Present–0.0001 |
see table 13 |
5436-43-1 |
PBDE-47 |
0.7 |
9 |
0 |
Present |
see table 13 |
60348-60-9 |
PBDE-99 |
0.7 |
9 |
0 |
Present–0.0048 |
see table 13 |
189084-64-8 |
PBDE-100 |
0.7 |
9 |
0 |
Present–0.0016 |
see table 13 |
68631-49-2 |
PBDE-153 |
1 |
9 |
0 |
0.00006–0.0004 |
see table 13 |
37680-73-2 |
PCB-101 |
0.5 |
1 |
0 |
Present |
Longview, see table 13 |
35065-29-3 |
PCB-180 |
0.5 |
3 |
0 |
0.00001–0.00002 |
see table 13 |
1825-21-4 |
Pentachloroanisole |
35 |
5 |
0 |
Present –0.00085 |
see table 13 |
85-01-8 |
Phenanthrene |
0.4 |
1 |
0 |
Present |
St. Helens, see table 9 |
129-00-0 |
Pyrene |
0.03 |
3 |
0 |
Present |
see table 9 |
83-46-5 |
beta-Sitosterol |
25 |
9 |
0 |
E 0.79–E 3.2 |
see table 9 |
83-45-4 |
beta-Stigmastanol |
75 |
5 |
0 |
Present–E 1.1 |
see table 9 |
3380-34-5 |
Triclosan |
70 |
8 |
0 |
Present–0.76 |
see tables 9 and 13 |
1582-09-8 |
Trifluralin |
1.1 |
3 |
0 |
Present–0.00002 |
see table 13 |
|
First posted April 25, 2012
Part or all of this report is presented in Portable Document Format (PDF); the latest version of Adobe Reader or similar software is required to view it. Download the latest version of Adobe Reader, free of charge. |